MULTIPLE CORONARY HEART-DISEASE RISK-FACTORS ARE ASSOCIATED WITH MENOPAUSE AND INFLUENCED BY SUBSTITUTIVE HORMONAL-THERAPY IN A COHORT OF FRENCH WOMEN

被引:86
作者
DALLONGEVILLE, J
MARECAUX, N
ISOREZ, D
ZYLBERBERG, G
FRUCHART, JC
AMOUYEL, P
机构
[1] INST PASTEUR,INSERM,U325,F-59019 LILLE,FRANCE
[2] INST PASTEUR,SERV SANTE PUBL,F-59019 LILLE,FRANCE
[3] INST PASTEUR,CTR EXAMEN SANTE,LILLE,FRANCE
关键词
MENOPAUSE; HORMONAL REPLACEMENT THERAPY; LIPOPROTEINS; APOLIPOPROTEINS; CHD RISK FACTOR; ESTROGEN; PROGESTIN;
D O I
10.1016/0021-9150(95)05599-R
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between menopause and cardiovascular risk factors, and the effect on these risk factors of progestin alone or in combination with estrogen were analysed in a sample of French women. Three thousand four hundred and forty consecutive women, between 45 and 65 years of age, who received a systematic check-up between January 1991 and April 1993 were enrolled in this study. All biological measurements were performed at a central laboratory. Women were classified as premenopausal (n = 1233), postmenopausal (n = 1774) if they had not menstruated in the 12 months before examination, and perimenopausal (n = 433) if they met at least two of the following criteria: elevated levels of serum follicle-stimulating hormone (FSH), irregular menses. amenorrhea for less than 12 months, hot flushes. The effect of menopause on cardiovascular risk factors was determined in 2167 women between 45 and 65 years of age (premenopausal n = 790, postmenopausal n = 1377), none of whom were presently treated with hormonal replacement therapy (HRT). In addition, the effect of progestin was assessed in a group of 397 perimenopausal women, and the effect of combined estrogen and progestin replacement therapy in another group of 1746 postmenopausal women. Menopause was associated with higher levels of serum cholesterol (6.4 vs. 5.9 mmol/l), triglycerides (1.2 vs. 1.0 mmol/l), apolipoprotein (apo) B (1.3 vs. 1.1 g/l), apo A-I (1.9 vs. 1.8 g/l), as well as with elevated diastolic blood pressure (79.7 vs. 77.0 mmHg). Multivariate analysis indicated that these effects were independent of age, body mass index (BMI), glycemia, smoking, alcohol intake, exercise and parity. Perimenopausal women treated with progestin alone (n = 95) were compared to perimenopausal women not using HRT (n = 302). There were no statistically significant differences in the levels of cholesterol, triglycerides, apo B, apo A-I, glycemia and blood pressure between the two groups. Postmenopausal women using a combination of estrogen and progestin (n = 369) had significantly lower levels of serum cholesterol (6.1 vs. 6.4 mmol/l), triglycerides (1.0 vs. 1.2 mmol/l), apo B (1.2 vs. 1.3 g/l), systolic (131.9 vs. 137.9 mmHg) and diastolic (76.9 vs. 79.7 mmHg) blood pressure than postmenopausal women without hormonal therapy (n = 1377), taking into account confounding variables. In contrast, serum apo A-I levels were not altered by the combined hormonal therapy. We conclude that menopause is associated with the aggravation of multiple cardiovascular risk factors. These deleterious factors are beneficially affected by a treatment combining estrogen and progestin.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 34 条
[1]   LONGITUDINAL AND SECULAR TRENDS IN LIPOPROTEIN CHOLESTEROL MEASUREMENTS IN A GENERAL-POPULATION SAMPLE - THE FRAMINGHAM OFFSPRING STUDY [J].
ANDERSON, KM ;
WILSON, PWF ;
GARRISON, RJ ;
CASTELLI, WP .
ATHEROSCLEROSIS, 1987, 68 (1-2) :59-66
[2]   ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN [J].
BARRETTCONNOR, E ;
BUSH, TL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14) :1861-1867
[3]   POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED [J].
BARRETTCONNOR, E ;
WINGARD, DL ;
CRIQUI, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14) :2095-2100
[4]   PLASMA-LIPID, LIPOPROTEIN CHOLESTEROL, AND APOPROTEIN DISTRIBUTIONS IN SELECTED UNITED-STATES COMMUNITIES - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
BROWN, SA ;
HUTCHINSON, R ;
MORRISETT, J ;
BOERWINKLE, E ;
DAVIS, CE ;
GOTTO, AM ;
PATSCH, W .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1139-1158
[5]  
BUSH TL, 1990, ANN NY ACAD SCI, V592, P263
[6]   CARDIOVASCULAR MORTALITY AND NONCONTRACEPTIVE USE OF ESTROGEN IN WOMEN - RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J].
BUSH, TL ;
BARRETTCONNOR, E ;
COWAN, LD ;
CRIQUI, MH ;
WALLACE, RB ;
SUCHINDRAN, CM ;
TYROLER, HA ;
RIFKIND, BM .
CIRCULATION, 1987, 75 (06) :1102-1109
[7]   LONG-TERM HORMONE REPLACEMENT TREATMENT IN MENOPAUSE - NEW CHOICES, OLD APPREHENSIONS, RECENT FINDINGS [J].
CAMPAGNOLI, C ;
LESCA, L ;
CANTAMESSA, C ;
PERIS, C .
MATURITAS, 1993, 18 (01) :21-46
[8]   DIFFERENCES IN LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN [J].
CAMPOS, H ;
MCNAMARA, JR ;
WILSON, PWF ;
ORDOVAS, JM ;
SCHAEFER, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :30-35
[9]  
CROOK D, 1993, NEW ENGL J MED, V329, P1041
[10]   MENOPAUSE AND CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
KANNEL, WB ;
HJORTLAND, MC ;
MCNAMARA, PM .
ANNALS OF INTERNAL MEDICINE, 1978, 89 (02) :157-161